An executive at AstraZeneca says breast-cancer drugs that the company highlighted at an industry conference over the weekend could represent $10 billion worth of company sales in five years’ time.
www.marketwatch.com
#AstraZeneca #hails #major #breakthroughs #breastcancer #drugs
AstraZeneca hails major breakthroughs with breast-cancer drugs
